| Gregory Gerard Lara, MD | |
|
1420 S Central Ave, Glendale, CA 91204-2508 | |
| (818) 502-2252 | |
| (818) 502-2317 |
| Full Name | Gregory Gerard Lara |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 28 Years |
| Location | 1420 S Central Ave, Glendale, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144244484 | NPI | - | NPPES |
| 00A811150 | Other | CA | BLUE SHIELD |
| 00A811150 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | A69087 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Methodist Hospital Of Southern Ca | Arcadia, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pacific Valley Medical Group | 3577465368 | 96 |
News Archive
A study published in the March 2011 Archives of Pediatrics and Adolescent Medicine shows that Massachusetts' new court-ordered mental health screening and intervention program led to more children being identified as behaviorally and emotionally at risk. The program is called the Children's Behavioral Health Initiative (CBHI).
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.
Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 - 45.
Frightening experiences do not quickly fade from memory. A team of researchers under the guidance of the University of Bonn Hospital has now been able to demonstrate in a study that the bonding hormone oxytocin inhibits the fear center in the brain and allows fear stimuli to subside more easily.
› Verified 2 days ago
| Entity Name | Pacific Valley Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851312862 PECOS PAC ID: 3577465368 Enrollment ID: O20040122000762 |
News Archive
A study published in the March 2011 Archives of Pediatrics and Adolescent Medicine shows that Massachusetts' new court-ordered mental health screening and intervention program led to more children being identified as behaviorally and emotionally at risk. The program is called the Children's Behavioral Health Initiative (CBHI).
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.
Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 - 45.
Frightening experiences do not quickly fade from memory. A team of researchers under the guidance of the University of Bonn Hospital has now been able to demonstrate in a study that the bonding hormone oxytocin inhibits the fear center in the brain and allows fear stimuli to subside more easily.
› Verified 2 days ago
| Entity Name | Ranger Anesthesia Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588131213 PECOS PAC ID: 3779823562 Enrollment ID: O20190313002427 |
News Archive
A study published in the March 2011 Archives of Pediatrics and Adolescent Medicine shows that Massachusetts' new court-ordered mental health screening and intervention program led to more children being identified as behaviorally and emotionally at risk. The program is called the Children's Behavioral Health Initiative (CBHI).
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.
Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 - 45.
Frightening experiences do not quickly fade from memory. A team of researchers under the guidance of the University of Bonn Hospital has now been able to demonstrate in a study that the bonding hormone oxytocin inhibits the fear center in the brain and allows fear stimuli to subside more easily.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gregory Gerard Lara, MD 225 S Lake Ave, 535, Pasadena, CA 91101-3005 Ph: (626) 795-6596 | Gregory Gerard Lara, MD 1420 S Central Ave, Glendale, CA 91204-2508 Ph: (818) 502-2252 |
News Archive
A study published in the March 2011 Archives of Pediatrics and Adolescent Medicine shows that Massachusetts' new court-ordered mental health screening and intervention program led to more children being identified as behaviorally and emotionally at risk. The program is called the Children's Behavioral Health Initiative (CBHI).
A study conducted in Denmark showed that 86% of Rebif®-treated patients found that injections were easier and less painful using the new needle. The pre-filled syringe of Rebif® with the new needle is available in the same dosages as the previous version and will continue to carry the same indication. It is currently being launched in Europe and will be available worldwide by the end of 2004.
Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.
Diabetes affects nearly 24 million people in the United States, most with Type 2 diabetes, a disease which is often coupled with obesity. Concerned by the increasing number of overweight Americans, nutrition experts with the UC San Diego School of Medicine are launching Take Charge, a research study analyzing the effectiveness of a commercial weight-loss program on participants with Type 2 diabetes who have a BMI of 25 - 45.
Frightening experiences do not quickly fade from memory. A team of researchers under the guidance of the University of Bonn Hospital has now been able to demonstrate in a study that the bonding hormone oxytocin inhibits the fear center in the brain and allows fear stimuli to subside more easily.
› Verified 2 days ago
Mrs. Asmik Akopyan, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1030 S. Glendale Ave., Suite 404, Glendale, CA 91205 Phone: 818-240-9911 Fax: 818-240-9939 | |
Michael S Winston, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 824 N Glendale Ave, Glendale, CA 91206 Phone: 818-500-0523 | |
Dwight E Hiscox, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-550-0900 Fax: 505-293-1524 | |
Yukiko Ree, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1812 Verdugo Blvd, Glendale, CA 91208 Phone: 818-790-7100 | |
Arthur Victor Liu, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Varner Edward Dudley Iii, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1509 Wilson Ter, Glendale, CA 91206 Phone: 818-409-8000 Fax: 818-546-5632 | |
Ivan Hronek, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1420 S Central Ave, Glendale, CA 91204 Phone: 818-502-1900 Fax: 818-502-4738 |